# Element Biosciences

Source: https://onco.cc/companies/element-biosciences/  
OnCo record `element-biosciences` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

AVITI benchtop sequencer with avidity chemistry, competing on accuracy and cost with mid-throughput Illumina systems.

## Summary

Element Biosciences, based in San Diego, makes the AVITI benchtop sequencer, which uses avidity chemistry to compete on accuracy and cost with mid-throughput Illumina systems. AVITI and AVITI24, which runs multiomics on a single instrument, were launched between 2022 and 2024. OnCo links it to new short-read sequencing platforms. Whether a benchtop challenger can win clinical laboratories away from the incumbent when assays are validated on Illumina is the open question. The short-read platforms page carries the wider picture.

## Fields

- Kind: Company
- Last checked: 2026-09-08
- Tags: supporting
- HQ: San Diego, CA
- Type: diagnostics
- Website: https://www.elementbiosciences.com

## Sources

- Official website: https://www.elementbiosciences.com

## Connected records

- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/)
- technologies: [New short-read sequencing platforms](https://onco.cc/technologies/next-gen-short-read-platforms/)

---
JSON: https://onco.cc/api/v1/entities/element-biosciences.json